These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27801337)

  • 1. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
    Jiang N; Li MT; Wu D; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
    Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
    Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
    Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
    Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
    Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis.
    Bennett TD; Fluchel M; Hersh AO; Hayward KN; Hersh AL; Brogan TV; Srivastava R; Stone BL; Korgenski EK; Mundorff MB; Casper TC; Bratton SL
    Arthritis Rheum; 2012 Dec; 64(12):4135-42. PubMed ID: 22886474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients.
    Gavand PE; Serio I; Arnaud L; Costedoat-Chalumeau N; Carvelli J; Dossier A; Hinschberger O; Mouthon L; Le Guern V; Korganow AS; Poindron V; Gourguechon C; Lavigne C; Maurier F; Labro G; Heymonet M; Artifoni M; Viau AB; Deligny C; Sene T; Terriou L; Sibilia J; Mathian A; Bloch-Queyrat C; Larroche C; Amoura Z; Martin T
    Autoimmun Rev; 2017 Jul; 16(7):743-749. PubMed ID: 28483541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
    Aoyama-Maeda N; Horino T; Ichii O; Terada Y
    Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Tulbă D; Balea M; Băicuş C
    Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eighty-six cases of clinical characteristics and outcomes of systemic lupus erythematosus-associated macrophage activation syndrome: A meta-analysis study.
    Wang J; Rong W; Yan H
    Immun Inflamm Dis; 2024 Aug; 12(8):e1364. PubMed ID: 39110110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
    Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
    Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
    Shah K; Porter A; Takhar G; Reddy V
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32269047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome].
    Xing XY; Zhang JX; Zhu FY; Wang YF; Zhou XY; Li YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1214-1218. PubMed ID: 36533358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome: A severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients.
    Gormezano NW; Otsuzi CI; Barros DL; da Silva MA; Pereira RM; Campos LM; Borba EF; Bonfá E; Silva CA
    Semin Arthritis Rheum; 2016 Jun; 45(6):706-10. PubMed ID: 26833399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
    Parodi A; Davì S; Pringe AB; Pistorio A; Ruperto N; Magni-Manzoni S; Miettunen P; Bader-Meunier B; Espada G; Sterba G; Ozen S; Wright D; Magalhães CS; Khubchandani R; Michels H; Woo P; Iglesias A; Guseinova D; Bracaglia C; Hayward K; Wouters C; Grom A; Vivarelli M; Fischer A; Breda L; Martini A; Ravelli A;
    Arthritis Rheum; 2009 Nov; 60(11):3388-99. PubMed ID: 19877067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
    Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
    Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
    Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
    Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
    Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
    J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute acalculous cholecystitis in patients with systemic lupus erythematosus: A unique form of disease flare.
    Yang H; Bian S; Xu D; Zhang F; Zhang X
    Lupus; 2017 Sep; 26(10):1101-1105. PubMed ID: 28355987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.
    Naveen R; Jain A; Muhammed H; Gupta L; Misra DP; Lawrence A; Agarwal V; Misra R; Aggarwal A
    Rheumatol Int; 2021 Mar; 41(3):625-631. PubMed ID: 33388903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.